DOJ Sues Healthpoint Over Zenaderm Marketing
By Sherry Mazzocchi · April 1, 2011, 7:13 PM EDT
The U.S. Department of Justice on Thursday accused Healthpoint Ltd. of falsely marketing the bedsore ointment Xenaderm as a prescription drug qualifying for Medicare and Medicaid reimbursement, causing the agencies to...
To view the full article, register now.